Join to View Full Profile
101 Manning DrChapel Hill, NC 27514
Phone+1 919-843-5795
Dr. Long is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Millie Long is a gastroenterologist in Chapel Hill, NC and is affiliated with multiple hospitals in the area, including University of North Carolina Hospitals and University of North Carolina Hospitals. She received her medical degree from University of Virginia School of Medicine and has been in practice 15 years. She specializes in inflammatory bowel disease and is experienced in general gastroenterology and inflammatory bowel disease.
Education & Training
University of North Carolina HospitalsResidency, Public Health and General Preventive Medicine, 2009 - 2010- University of North Carolina HospitalsFellowship, Gastroenterology, 2007 - 2009
University of Alabama Medical CenterResidency, Internal Medicine, 2002 - 2006
University of Virginia School of MedicineClass of 2002
Certifications & Licensure
NC State Medical License 2006 - 2026
TX State Medical License 2023 - 2023
AL State Medical License 2004 - 2006
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Registry for Participants With Short Bowel Syndrome Start of enrollment: 2014 Jun 23
- Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center Study Start of enrollment: 2018 Nov 27
Publications & Presentations
PubMed
- MUSings on a Crohn's Disease Diagnosis.Meera Iyengar, Animesh Jain, Hans H Herfarth, Millie D Long, Edward L Barnes
Digestive Diseases and Sciences. 2025-06-26 - A Prospective Comparison of Ustekinumab and Anti-TNF Therapy in the Treatment of Crohn's-like Disease of the Pouch.Edward L Barnes, Laura Raffals, Taha Qazi, Parakkal Deepak, Shannon Chang
The American Journal of Gastroenterology. 2025-06-25 - 1 citationsPredicting Outcomes in Hospitalized Patients With Acute Severe Ulcerative Colitis in a Prospective Multicenter Cohort.Lara Chaaban, Benjamin Cohen, Raymond K Cross, Maia Kayal, Millie Long
Inflammatory Bowel Diseases. 2025-06-13
Journal Articles
- Social Media Use and Preferences in Patients with Inflammatory Bowel DiseaseMillie D Long, Francis A Farraye, Inflammatory Bowel Diseases
- Correction to: Inflammatory Bowel Diseases Can Adversely Impact Domains of Sexual Function Such as Satisfaction with Sex LifeMichael D Kappelman, Swathi Eluri, Robert S Sandler, Millie D Long, Raymond K Cross, Digestive Diseases and Sciences
Press Mentions
TREMFYA® (Guselkumab) Positioned to Become the First and Only IL-23 Inhibitor to Offer Subcutaneous Induction in Ulcerative Colitis as Demonstrated in New Data Through 24 WeeksMay 5th, 2025- Treat IBD with Confidence: Clinical Strategies That Make a DifferenceApril 30th, 2025
- ACG Observes Irritable Bowel Syndrome Awareness MonthApril 18th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
